Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3504 Target Snapshot

Glutamate receptor 3 · SINGLE PROTEIN · Rattus norvegicus

84Compounds
39Assays
0Approved Drugs
110.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P19492. Use UniProt P19492 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P19492 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Glutamate receptor 3 as ChEMBL target CHEMBL3504, mapped to UniProt P19492. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Glutamate receptor 3
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL3504
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P19492
Glutamate receptor 3
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Glutamate receptor 3 is the right protein anchor across sources, using UniProt P19492 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelGlutamate receptor 3
UniProt AccessionP19492
Component TypeProtein
Sequence Length888 aa

Glutamate receptor 3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Glutamate receptor 3, mapped to UniProt P19492. Sequence length is 888 aa.

Mapped IDP19492
Review nameGlutamate receptor 3
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

2
Phase III
2
Phase II
Assay Mix

Activity Type Distribution

IC508.0
KI63.0
EC5039.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL13378 10.68 Ki 0.021 Preclinical
CHEMBL370941 10.35 Ki 0.045 Preclinical
CHEMBL388746 9.41 Ki 0.39 Preclinical
CHEMBL372643 8.92 Ki 1.2 Preclinical
CHEMBL94859 8.66 Ki 2.2 Preclinical
CHEMBL193087 8.43 Ki 3.7 Preclinical
CHEMBL276815 7.68 Ki 21.0 Preclinical
CHEMBL1096289 7.19 IC50 64.0 Preclinical
CHEMBL123132 7.16 Ki 70.0 Preclinical
CHEMBL12442 7.0 EC50 100.0 Preclinical
Distribution

pChEMBL Value Distribution

9
5.0
11
5.5
8
6.0
3
6.5
4
7.0
3
7.5
1
8.0
2
8.5
1
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

39
Total Assays
48
Tested Compounds
2
Assay Types
Binding — 25 assays, 48 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 20 44 6.0
single protein format 4 3 5.9
assay format 1 1 5.7
Functional — 14 assays, 15 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 14 15 5.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine